Healthcare Regulations & Licensing Flashcards

Under DHA regulations, a licensed physician who performs a procedure outside the explicitly defined scope of their specialty license without obtaining a temporary privilege waiver is subject to which primary regulatory consequence?

Answer: Mandatory referral to the Dubai Medical Liability Committee for determination of unauthorized practice

Under DHA's medical liability and scope-of-practice framework, performing procedures outside one's licensed specialty without an approved privilege waiver constitutes unauthorized practice, which mandates referral to the Dubai Medical Liability Committee. The committee—not the Licensing Department alone—has jurisdiction to determine liability and sanctions. A warning or provisional downgrade does not satisfy the statutory referral requirement in such cases.

A DHA-licensed healthcare facility wishes to add a new specialty service line (e.g., bariatric surgery) not covered in its current facility license. Which sequence of approvals correctly reflects the DHA regulatory pathway?

Answer: Obtain DHA Facility Licensing approval for the new specialty, confirm the availability of at least one licensed specialist, then update the facility's scope-of-services register

DHA requires that any expansion of a facility's approved specialty services follow a defined sequence: first, the facility license amendment must be approved by DHA Facility Licensing confirming infrastructure and staffing standards are met; second, at least one fully licensed DHA practitioner in that specialty must be confirmed; and third, the scope-of-services register must be updated. Credentialing a specialist before facility approval, or filing a quality-improvement plan as a workaround, does not satisfy the regulatory sequence.

According to DHA licensing regulations, which scenario would make a foreign-trained physician ineligible for the 'Equivalency Route' to DHA licensure, even if they hold a valid license in their country of training?

Answer: The physician's primary medical degree is from a university not listed in the DHA/WHO-recognized institution list

The DHA Equivalency Route requires that the applicant's primary medical qualification originate from a university recognized by both the DHA and the World Directory of Medical Schools (formerly WHO list). If the institution is not on this recognized list, the applicant is categorically ineligible for the equivalency pathway and must pursue alternative routes such as examination-based licensure. Program length and holding multiple specialty licenses are not automatic disqualifiers.

A DHA-licensed nurse practitioner (NP) employed in a primary care clinic wants to independently prescribe a Schedule 3 controlled substance to a patient without co-signature from a physician. Under current DHA prescribing authority rules, this action is:

Answer: Prohibited entirely; DHA nurse practitioners do not hold independent prescribing authority for any controlled substance schedule

Under DHA's scope-of-practice framework, nurse practitioners in Dubai do not have independent prescribing authority for controlled substances under any schedule. Controlled substance prescriptions require a licensed physician's order. While NPs may have expanded clinical roles under supervision, prescribing controlled substances independently—regardless of schedule—falls outside their licensed authority. The pharmacology module option does not confer controlled-substance prescribing rights.

A DHA facility license is due for renewal. The facility received two 'major non-conformance' findings during its last accreditation survey (conducted by an accreditation body approved by DHA). Under DHA renewal regulations, what is the most likely required action before the license renewal can be finalized?

Answer: Submission and DHA acceptance of a corrective action plan (CAP) with evidence of closure for all major non-conformances

DHA requires that major non-conformance findings from accreditation surveys be addressed through a formal corrective action plan (CAP) submitted to DHA. Renewal of the facility license is contingent on DHA accepting the CAP and receiving documented evidence (closure evidence) that the major findings have been resolved. Financial penalties, automatic admissions suspensions, and fixed 6-month deferrals are not the standard pathway—the CAP-with-evidence process is the regulatory mechanism that gates license renewal.

Under DHA's Medical Fitness Regulations, a licensed healthcare professional is newly diagnosed with a condition listed in the DHA Medical Fitness Schedule as 'Category B — Conditionally Fit.' Which obligation does this create for the practitioner?

Answer: Self-disclosure to the DHA Health Regulation Department within the mandated timeframe, with submission of a specialist assessment confirming fitness to practice with or without reasonable accommodations

DHA's Medical Fitness Regulations place an affirmative duty on licensed practitioners to self-disclose newly diagnosed Category B conditions to the DHA Health Regulation Department within the stipulated timeframe (not merely at renewal). The disclosure must be accompanied by a specialist assessment documenting the practitioner's fitness to continue practicing, with or without accommodations. Restricting notification to the employer or deferring to the renewal cycle does not satisfy the practitioner's regulatory disclosure obligation. Category A conditions (absolutely unfit) and Category B differ in outcome but not in the disclosure requirement.